(Total Views: 115)
Posted On: 06/28/2022 9:01:17 AM
Post# of 25306
$AEI Impact BioMedical Announces License Agreement with ProPhase Labs (NASDAQ: PRPH $12.98) to Produce and Distribute Viral-Fighting Compound Equivir
https://finance.yahoo.com/news/impact-biomedi...00349.html
Impact Biomedical, Inc., a wholly owned subsidiary of DSS
$AEI Owns 28.2% of DSS, from last Q
Zacks Small-Cap Research on DSS Valuation $1
https://s27.q4cdn.com/906368049/files/News/20...ompson.pdf
https://finance.yahoo.com/news/impact-biomedi...00349.html
Impact Biomedical, Inc., a wholly owned subsidiary of DSS
$AEI Owns 28.2% of DSS, from last Q
Zacks Small-Cap Research on DSS Valuation $1
https://s27.q4cdn.com/906368049/files/News/20...ompson.pdf
(0)
(0)Scroll down for more posts ▼
